期刊文献+

Tet-on Advanced调控人血管生素-1基因真核表达载体的构建、表达与鉴定

Construction and identification of human Angiopoietin-1 eukaryotic expression vector regulated by Tet-on Advanced system
下载PDF
导出
摘要 目的构建pTRE-Tight-Ang-1可调控性真核表达载体,并检测其在心脏细胞中表达的可调控性。方法巢式多聚酶链反应(nested PCR)从肺组织扩增Ang-l,测序正确后将其亚克隆入pTRE-Tight载体中,采用脂质体将pTet-on-Advanced质粒和pTRE-Tight-Ang-1共转染入新生SD大鼠心肌细胞,以不同浓度强力霉素(Dox)诱导,Western blot检测Ang-1蛋白表达水平。结果通过巢式PCR获得了Ang-1全长cDNA,与Genebank比对,序列完全一致。Western blot检测表明,所构建的pTRE-Tight-Ang-1可调控性表达载体能在心肌细胞内表达,表达量呈浓度依赖性。结论该实验成功构建pTRE-Tight-Ang-1真核表达载体,在心肌细胞中的表达受Dox的调控。 [Objective] To construct tetracychne (Tet) --controlled inducible vector pTRE-Tight-Ang-1, and then determinate expression character of Ang-1 under the regulation of Dox in cadioeyte. [Method] Ang-1 gene was amplified by nested PCR from the fresh lung tissue eDNA and the sequence was compared with Genebank data, and then sub-cloned into the pTRE-Tight plasmid after sequence analysis. PTRE- Tight-Ang-1 and pTet-on-Advanced were cotransfected with Lipofectamine 2000 TM to neonatal rat cadiocyte, expression of Ang-1 was assayed by Western blot after giving different concentration of Dox. [Results] The full-length of Ang-1 was obtained by nested PCR and identified by sequencing. Western blot showed that expression of Ang-1 could be induced by Dox in cadiocyte and shown in dose-dependent manner.[Conclusion] Tet-on inducible recombinant vector of pTRE- Tight-Ang-1 was successfully constructed, and its expression can be induced by DOX. This work has laid founda tions for further study on IHD (ischemic heart disease).
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第13期1841-1844,1848,共5页 China Journal of Modern Medicine
基金 国家自然科学基金资助项目(No:30672081)
关键词 ANG-1 Tet-on-advanced 可调控表达载体 真核表达 Ang-1 Tet-on-advanced inducible expression vector , eukaryotic expression
  • 相关文献

参考文献1

二级参考文献11

  • 1刘萱,李楚芳,李平,曹诚军.H1启动子siRNA载体的构建及应用[J].生物技术通讯,2004,15(5):444-446. 被引量:4
  • 2张秉强,唐霓,黄爱龙,闫歌,陶鹏,Tong-Chuan He,张君.shRNA表达载体构建方法的优化[J].生物技术通报,2004,20(6):47-49. 被引量:4
  • 3邱昕,潘纪安,陈宇,张苏明,郭德银.小干扰RNA对人淀粉样前体蛋白基因的沉默作用(英文)[J].中国现代医学杂志,2005,15(6):801-805. 被引量:8
  • 4BREKKEN RA,THORPE PE.Vascular endothelial growth factor and vascular argeting of solid rumors[J].Antieuneer Rcs,2001,21(6B):4221-4229.
  • 5FOLKMAN J.What is the evidence that tumors ale angiogenesis dependent[J].Natl Cancer lnst,1990,82:4-6.
  • 6KAPADIA SB,BRIDEAU ANDERSEN A,CHISARI FV.Interference of hepatits C virus RNA replication by short interfering RNAs[J].Proc Natl Acad Sci USA,2003,100(4):2014-2018.
  • 7REYNOLDSA,LEAKE D,BOESE Q,et al.Rational siRNA design for RNA interference[J].Nat Biotechnol,2004,22 (3):326-330.
  • 8CELOTTO AM,GRAVELEY BR.Exonspecific RNAi:a tool for dissecting the funetional relevance of alternative splicing[J].RNA,2002,8(6):718-724.
  • 9MULKEEN A,SILVA T,SCHMITZ J,et al.SiRNA-mediated gene silencing in colorectal cancer:a novel anti-angiogenic targeted therapy[J].Journal of Surgical Research,2004,121 (2):279-280.
  • 10TAKEI Y,KADOMATSU K,YUZAWA Y,et al.A small interfeting RNA targeting vascular endothelial growth factor as cancer therapeutics[J].Cancer Rcs,2004,64:3365-3370.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部